HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Antiischemic effect of intracoronary diltiazem on myocardial ischemia during PTCA.

Abstract
To evaluate the effect of intracoronary diltiazem on myocardial ischemia during percutaneous transluminal coronary angioplasty (PTCA), 38 patients were randomly assigned to receive inactive placebo (n = 19; group C) or a low dose (1 mg, n = 10; group D1), or a high dose (2 or 3 mg, n = 9; group D2) of diltiazem in a double-blind manner. The agent was administered directly into the coronary artery via a balloon catheter following a control balloon inflation. Chest pain score (maximum, 10) and the magnitude of ischemic ST elevation on standard and intracoronary electrocardiograms (ECGs) during a balloon inflation were assessed in the control and posttreatment periods. After the administration of diltiazem, the chest pain score was significantly decreased in group D1 (control: 5.1 +/- 3.6, posttreatment: 3.8 +/- 3.1, P < 0.01) and group D2 (3.4 +/- 2.5 vs 2.5 +/- 2.0, P < 0.01), but not in group C (4.1 +/- 3.1 vs 3.7 +/- 3.3, difference not significant). The magnitude of ST elevation relative to the control on standard and intracoronary ECGs was significantly smaller in groups D1 and D2 than in group C (standard ECG; D1: 51.8 +/- 10.6% of control, D2: 41.6 +/- 28.7% vs C: 93.3 +/- 15.6% and intracoronary ECG; D1: 47.1 +/- 11.7% of control, D2: 27.5 +/- 26.9% vs C: 94.6 +/- 29.3%, all P < 0.01). Although systolic blood pressure decreased slightly in groups D1 and D2, there was no significant correlation between the change in ST elevation and the change in the rate-pressure product. Pretreatment with a small dose of intracoronary diltiazem attenuated myocardial ischemia during PTCA and this pretreatment may enable us to perform balloon inflation for a longer period.
AuthorsK Saito, H Nonogi, Y Goto, A Itoh, S Daikoku, S Miyazaki, K Haze
JournalHeart and vessels (Heart Vessels) Vol. 11 Issue 2 Pg. 92-9 ( 1996) ISSN: 0910-8327 [Print] JAPAN
PMID8836757 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Calcium Channel Blockers
  • Diltiazem
Topics
  • Angina Pectoris (therapy)
  • Angioplasty, Balloon, Coronary
  • Calcium Channel Blockers (administration & dosage, therapeutic use)
  • Coronary Disease (therapy)
  • Coronary Vessels
  • Diltiazem (administration & dosage, therapeutic use)
  • Double-Blind Method
  • Electrocardiography
  • Female
  • Humans
  • Injections, Intra-Arterial
  • Male
  • Middle Aged
  • Myocardial Reperfusion Injury (etiology, prevention & control)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: